Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-07-20 · accession 0001104659-23-083556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-24 | 2023-07-20 | OBIO | Smith Geoffrey Wade | Dir | A - Grant | $0.00 | +16.7K | 20.9K | +393% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2023-07-20 | A | A | 16,667 | $0.00 | 20,913 | D | — | — | (F1) Represents restricted stock units that vest in full on July 20, 2024, subject to the Reporting Person's continued service with Orchestra BioMed Holdings, Inc. on such vesting date. |